chevron_leftBack
As of 13 June 2026, Optipharm.CO.,LTD has a market cap of $50.55M USD, ranking #30512 globally and #1737 in South Korea.
It ranks #2754 in the Healthcare sector, and #967 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$50.55MUSD
76.87B KRW
Enterprise Value
$50.81MUSD
77.54B KRW
Revenue (TTM)
$14.69MUSD
22.34B KRW
EBITDA (TTM)
-$484.81KUSD
-739.92M KRW
Net Income (TTM)
-$1.64MUSD
-2.5B KRW
EBITDA Margin
-3.3%
Profit Margin
-11%
PS Ratio
3.4
PB Ratio
3.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Founded
2000
Website
optipharm.co.kr
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.6% | -3.9% | 3.2% | -9.5% | 5.8% | -0.6% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
153710
(주)옵티팜
ISIN: KR7153710009
Shares Out.:
Shares Outstanding:
14.67M1
Shares Float:
8.646M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
5,240 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Optipharm.CO.,LTD
Optipharm.CO.,LTD operates as a biomedical solution provider in South Korea. It also engages in animal disease diagnosis, animal medicine, bacteriophage, Medipig, xenogenic organs, VLP vaccines, xenotransplantation, and other optipharm products, as well as veterinary drug for feed additives and laboratory animal Medipig business. The company was formerly known as Optiparm Solution Co., Ltd. and changed its name to Optipharm.CO.,LTD in 2012. Optipharm.CO.,LTD was founded in 2000 and is based in Cheongju, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 0126Z0
|
$9.15B
18K%
13.91T KRW
|
-
|
|
KRX: 000250
|
$6.77B
13K%
10.3T KRW
|
1958.1
|
|
KRX: 326030
|
$5.24B
10K%
7.97T KRW
|
29.9
|
|
KRX: 298380
|
$4.96B
10K%
7.55T KRW
|
-
|
|
KRX: 000100
|
$4.55B
9K%
6.92T KRW
|
35.9
|
|
KRX: 141080
|
$4.44B
9K%
6.76T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
2M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
1M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
713K%
|
97.4
|
|
SIX: RO
|
$321.52B
636K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
571K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
543K%
218.9B CHF
|
20.5
|
chevron_leftBack